$DPER-0007- 300M A/S - no ideas since 2007 !(but....) >>>>
since 2007. The only differences i see is on TX SOS and their last otcmarket filing I see a Matthew Markin Listed as president but otcmarkets I see a Michael De Haven as President, Secretary so not sure if he was in before or after 2007. I will keep digging. They are CE right now so if people buying outside of ihub I wonder why. Is it just some group push or are they gonna get this pos active again?
Mr. Matthew Markin has been the Chairman and President of Potash America, Inc. since March 18, 2013 and serves as its Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer. Mr. Markin has been the Chief Executive Officer, President and Secretary of US Tungsten Corp. since April 12, 2011 and serves as its Chief Financial Officer and Principal Accounting Officer. Mr. Markin serves as Principal Accounting Officer at American Lithium Minerals Inc. He serves as the President, Chief Executive Officer and Secretary of Deep Earth Resources, Inc. He served as Treasurer of US Tungsten Corp. since April 12, 2011. He served as Secretary and Treasurer of American Lithium Minerals, Inc. from May 13, 2008 to March 8, 2010. He served as the President of Harris Exploration, Inc. He served as the Chief Executive Officer, Chief Financial Officer, Principal Accounting Officer and Secretary of Intercontinental Resources, Inc. and served as its President since June 2003. Mr. Markin served as the Chief Executive Officer and President of American Lithium Minerals, Inc. from May 13, 2008 to October 2009 and its Principal Financial Officer until November 2009. He served as the President, Chief Financial Officer, Secretary and Treasurer of La Burbuja Cafe Inc. since January 31, 2007. He served as Secretary and Principal Accounting Officer of China Valves Technology, Inc. since June 2003. He served as an Executive Officer of Sensor System Solutions Inc. Since 1985, Mr. Markin has been involved in operations, management and financial equipping of several successful corporations both privately and publicly. His career span over 20 years in the investment banking industry with extensive knowledge and proven management expertise within the reverse merger sector. Mr. Markin specializes in forecasting, projections and market analysis, research and development. He advises on strategic matters concerning mergers and acquisitions as well as guiding companies into the public marketplace. He served as Chief Executive Officer of China Valves Technology, Inc. from June 2003 to December 2007 and its President since June 2003 and Chief Financial Officer from June 2003 to March 29, 2008. Mr. Markin served as the President of The Markin Group of Companies in Los Angeles, California since 1999. From 1992 to 1999, he served as Vice President of Canyon Financial Group, and investment banking firm. Previously, he founded and operated a successful real estate development company specializing in commercial and apartment buildings. Mr. Markin also served as Vice President of Operations & Real Estate of The Neptune Society Inc. Prior to that, he also served as the President for the Canyon Financial and Abacus Equities Corp. He served as Chairman of American Lithium Minerals Inc. He has been a Director of US Tungsten Corp. since April 12, 2011 and American Lithium Minerals, Inc. since May 13, 2008. He served as a Director of Harris Exploration, Inc. Mr. Markin served as a Director of Intercontinental Resources, Inc. and China Valves Technology, Inc. since June 2003. He serves as a Director of Deep Earth Resources, Inc. He served as a Director of La Burbuja Cafe Inc. since January 31, 2007. He served as a Director of Spectre Industries Inc. since October 20, 2003. He served as Director of WaferGen Biosystems, Inc. Mr. Markin studied graduate degrees in Science from Capilano College and the University of British Columbia, both in Vancouver.
SMART MONEY GOING INTO $GALE THIS AM. $GALE CHART: Golden Cross and closed above 50 and 200mda. Chart looks crazy pimping. Next Biotech play imo. Just finsihed a $40 million financing so they can commercialize their recently approved FDA drug. Grab em premarket if ya can.
News 
Market Data 
Discover 
AI
